↓ Skip to main content

Caplacizumab: First Global Approval

Overview of attention for article published in Drugs, October 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
153 Dimensions

Readers on

mendeley
172 Mendeley
Title
Caplacizumab: First Global Approval
Published in
Drugs, October 2018
DOI 10.1007/s40265-018-0989-0
Pubmed ID
Authors

Sean Duggan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 172 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 172 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 35 20%
Student > Ph. D. Student 21 12%
Researcher 17 10%
Student > Master 14 8%
Student > Doctoral Student 10 6%
Other 13 8%
Unknown 62 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 41 24%
Medicine and Dentistry 18 10%
Immunology and Microbiology 12 7%
Agricultural and Biological Sciences 9 5%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Other 17 10%
Unknown 68 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2023.
All research outputs
#6,884,118
of 24,932,434 outputs
Outputs from Drugs
#1,179
of 3,452 outputs
Outputs of similar age
#115,527
of 352,711 outputs
Outputs of similar age from Drugs
#19
of 35 outputs
Altmetric has tracked 24,932,434 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 3,452 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,711 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.